Notably, exposure of ECs to COVID-19 plasma characterized by elevated proinflammatory cytokine levels (specifically, IL-1β, IL-6, and TNF-α) precipitated a redox-sensitive upregulation of SGLT-2 expression. The gene discussed is SLC5A2; the disease is COVID-19.